Pharming Group (PHAR) Earnings Date & Reports

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHAR is expected to report earnings to fall 180.43% to 5 cents per share on July 30

Pharming Group PHAR Stock Earnings Reports

Q2'26

Est.

$0.06

Q1'26

Missed

by $0.08

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.10

Q2'25

Beat

by $0.07

The last earnings report on May 07 showed earnings per share of -7 cents, missing the estimate of 0 cents. With 5.33K shares outstanding, the current market capitalization sits at 966.75M.

View a ticker or compare two or three

Compare

PHAR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PHAR